jeudi 20 novembre 2014

Novartis holding UK government to ransom with Bexsero pricing

http://ift.tt/1yuLrUU



Wrangling over life-saving meningitis vaccine may cost 'hundreds of children’s lives':



http://ift.tt/14SsaUy



' There have been more than 1,000 cases of meningitis B since the vaccine was licensed in the UK last year. It is estimated that as many as 100 of these cases will have resulted in death, with another 300 affected by disability. The Department of Health said an “expert independent committee” had set a “cost-effective price for the vaccine and that the Government was determined to introduce it. “Negotiations,” the department said, “are continuing." '



There is no chance at this time for the vaccine to be widely sold regardless of price; the vaccine cannot be made because of serious production problems. So the strategy is for Novartis to remain obstinate on the ridiculous price to bide time until enough vaccine can be produced.



Meanwhile Pfizer will gain EU approval for their MenB vaccine that was just approved in the US and will swoop in to undercut NVS, except by that time GSK will be holding the Bexzero diaper bag. Hilarious.





Novartis holding UK government to ransom with Bexsero pricing

Aucun commentaire:

Enregistrer un commentaire